These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6625977)

  • 1. Financing of clinical trials.
    van den Noort S
    Arch Neurol; 1983 Oct; 40(11):697-9. PubMed ID: 6625977
    [No Abstract]   [Full Text] [Related]  

  • 2. Choice of therapeutic agents for trial.
    Johnson KP; Santos GW
    Arch Neurol; 1983 Oct; 40(11):695-6. PubMed ID: 6625976
    [No Abstract]   [Full Text] [Related]  

  • 3. [Medical insurance aspects of human experiments].
    Staak M
    Lebensversicher Med; 1979 Jan; 32(1):12-6. PubMed ID: 43933
    [No Abstract]   [Full Text] [Related]  

  • 4. Reimbursement issues in cancer clinical trials.
    McKenna RJ
    Cancer; 1990 May; 65(10 Suppl):2405-6. PubMed ID: 2346567
    [No Abstract]   [Full Text] [Related]  

  • 5. Breakout II. Reimbursement concerns.
    Henney JE; Greene T; Aronson N; Johnson JE; McCabe M; Monaco GP; Poulter CA
    Cancer; 1990 May; 65(10 Suppl):2409-10. PubMed ID: 2334881
    [No Abstract]   [Full Text] [Related]  

  • 6. Third-party payers and investigational therapy.
    N Engl J Med; 1988 Nov; 319(18):1228. PubMed ID: 3173464
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental therapy--who shall pay?
    N Engl J Med; 1991 May; 324(18):1291-2. PubMed ID: 2014045
    [No Abstract]   [Full Text] [Related]  

  • 8. Anemia trials: lessons for clinicians, politicians, and third-party payers.
    Szczech L
    Kidney Int; 2010 Mar; 77(6):479-80. PubMed ID: 20186158
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter to the editors: response to payer coverage for patients enrolled onto clinical trials.
    Wong YN; Ward J; Neuss M
    Am J Manag Care; 2012 Nov; 18(11):e438. PubMed ID: 23198753
    [No Abstract]   [Full Text] [Related]  

  • 10. Barriers to clinical trials. Part I: Reimbursement problems.
    Fleming ID
    Cancer; 1994 Nov; 74(9 Suppl):2662-5. PubMed ID: 7954282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissemination of information on legislative mandates and consensus-based programs addressing payment of the costs of routine care in clinical trials through the World Wide Web.
    Monaco V
    Cancer; 2004 Dec; 101(11):2709-10; author reply 2710. PubMed ID: 15382087
    [No Abstract]   [Full Text] [Related]  

  • 12. Payer coverage for patients enrolled onto clinical trials: making the process easy and transparent for everyone.
    Palackdharry CS; Evans DL; McDonough RS; Clarke ME; Cross JD; Klein IM; Reisman L
    Am J Manag Care; 2012 May; 18(5 Spec No. 2):SP91-7. PubMed ID: 22693988
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer clinical trials. A case for collaboration.
    Purvis JD
    Cancer; 1990 May; 65(10 Suppl):2391-3. PubMed ID: 2334880
    [No Abstract]   [Full Text] [Related]  

  • 14. Common problems in designing therapeutic trials in multiple sclerosis.
    Weiss W; Dambrosia JM
    Arch Neurol; 1983 Oct; 40(11):678-80. PubMed ID: 6625975
    [No Abstract]   [Full Text] [Related]  

  • 15. Viewpoint: hospitals often play important role as intermediaries of patients in clinical research programs.
    Hochhauser M
    Patient Care Manag; 2002 Jun; 17(9):1, 4-6. PubMed ID: 12087591
    [No Abstract]   [Full Text] [Related]  

  • 16. Why non-inferiority is more challenging than superiority?
    Sormani MP
    Mult Scler; 2017 May; 23(6):790-791. PubMed ID: 28350235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A working protocol to be used as a guideline for trials in multiple sclerosis.
    Weiner HL; Ellison GW
    Arch Neurol; 1983 Oct; 40(11):704-10. PubMed ID: 6625981
    [No Abstract]   [Full Text] [Related]  

  • 18. Reimbursement for clinical investigation.
    Oldham RK
    Pharos Alpha Omega Alpha Honor Med Soc; 1991; 54(2):33. PubMed ID: 2068219
    [No Abstract]   [Full Text] [Related]  

  • 19. Reimbursement for patients enrolled in clinical trials.
    Kennedy BJ
    Cancer Invest; 1994; 12(4):444-6. PubMed ID: 8032968
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient selection and criteria.
    Paty DW; Davis FA
    Arch Neurol; 1983 Oct; 40(11):701. PubMed ID: 6625979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.